Literature DB >> 25184829

In vitro and in vivo antimalarial activity of amphiphilic naphthothiazolium salts with amine-bearing side chains.

Peter Ulrich1, Gregory R Gipson1, Martha A Clark1, Abhai Tripathi1, David J Sullivan1, Carla Cerami2.   

Abstract

Because of emerging resistance to existing drugs, new chemical classes of antimalarial drugs are urgently needed. We have rationally designed a library of compounds that were predicted to accumulate in the digestive vacuole and then decrystallize hemozoin by breaking the iron carboxylate bond in hemozoin. We report the synthesis of 16 naphthothiazolium salts with amine-bearing side chains and their activities against the erythrocytic stage of Plasmodium falciparum in vitro. KSWI-855, the compound with the highest efficacy against the asexual stages of P. falciparum in vitro, also had in vitro activity against P. falciparum gametocytes and in vivo activity against P. berghei in a murine malaria model. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25184829      PMCID: PMC4183413          DOI: 10.4269/ajtmh.13-0565

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

1.  Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins.

Authors:  Miriam Krugliak; Jianmin Zhang; Hagai Ginsburg
Journal:  Mol Biochem Parasitol       Date:  2002-02       Impact factor: 1.759

Review 2.  Antimalarial drug discovery: efficacy models for compound screening.

Authors:  David A Fidock; Philip J Rosenthal; Simon L Croft; Reto Brun; Solomon Nwaka
Journal:  Nat Rev Drug Discov       Date:  2004-06       Impact factor: 84.694

3.  The structure of malaria pigment beta-haematin.

Authors:  S Pagola; P W Stephens; D S Bohle; A D Kosar; S K Madsen
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

4.  A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle.

Authors:  Blandine Franke-Fayard; Holly Trueman; Jai Ramesar; Jacqui Mendoza; Maarten van der Keur; Reinier van der Linden; Robert E Sinden; Andrew P Waters; Chris J Janse
Journal:  Mol Biochem Parasitol       Date:  2004-09       Impact factor: 1.759

5.  The shape and size of hemozoin crystals distinguishes diverse Plasmodium species.

Authors:  Gregory S Noland; Noelle Briones; David J Sullivan
Journal:  Mol Biochem Parasitol       Date:  2003-08-31       Impact factor: 1.759

6.  Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum.

Authors:  Naomi Campanale; Christine Nickel; Claudia A Daubenberger; Dean A Wehlan; Jeff J Gorman; Nectarios Klonis; Katja Becker; Leann Tilley
Journal:  J Biol Chem       Date:  2003-05-14       Impact factor: 5.157

7.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

8.  Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China.

Authors:  Henglin Yang; Dequan Liu; Yaming Yang; Bo Fan; Pinfang Yang; Xingliang Li; Chunfu Li; Ying Dong; Cangjiang Yang
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Mar-Apr       Impact factor: 2.184

Review 9.  Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions.

Authors:  Katja Becker; Leann Tilley; Jonathan L Vennerstrom; David Roberts; Stephen Rogerson; Hagai Ginsburg
Journal:  Int J Parasitol       Date:  2004-02       Impact factor: 3.981

10.  A flow cytometry-based quantitative drug sensitivity assay for all Plasmodium falciparum gametocyte stages.

Authors:  Zenglei Wang; Min Liu; Xiaoying Liang; Salil Siriwat; Xiaolian Li; Xiaoguang Chen; Daniel M Parker; Jun Miao; Liwang Cui
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.